Results 1 to 10 of about 25,215 (206)
PYRAZINAMIDE INDUCED ACUTE GOUTY ARTHRITIS
Journal of Nepal Medical Association, 2003 A typical case of pyrazinamide induced acute gouty arthritis in a tuberculous patient with antitubercular therapy including pyrazinamide was reported.
U N Pathak, B O Shrestha, R R Shrestha
doaj +3 more sources
BMC Infectious Diseases, 2020 Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs and regimens including bedaquiline and linezolid.
Hui Xia +6 more
doaj +2 more sources
Association between overexpression of efflux pumps genes Rv0191 and Rv3008 and pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis: a multi-center study [PDF]
BMC Infectious DiseasesBackground Pyrazinamide is a drug that helps shorten the duration of tuberculosis treatment. Mutations in the pncA are the most common mechanism of pyrazinamide resistance in M. tuberculosis.
Mohammad Hashemzadeh +4 more
doaj +2 more sources
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation. [PDF]
PLoS ONE, 2017 Pyrazinamide is the main driver of sterilizing effect in the standard regimen in adults and older children, and this effect is concentration-dependent. Tuberculosis patients co-infected with human immunodeficiency virus (HIV) have an increased risk for ...
Christopher Vinnard +9 more
doaj +2 more sources
Pyrazinamide resistance in rifampicin discordant tuberculosis.
PLoS ONE, 2022 IntroductionMycobacterium tuberculosis strains with phenotypically susceptible rpoB mutations (rifampicin discordant) have emerged following implementation of rapid molecular drug resistance testing for tuberculosis. Whilst rifampicin resistance is known
Nomonde Ritta Mvelase +3 more
doaj +2 more sources
Frontiers in Pharmacology, 2023 Objectives: This study was performed to develop a population pharmacokinetic model of pyrazinamide for Korean tuberculosis (TB) patients and to explore and identify the influence of demographic and clinical factors, especially geriatric diabetes mellitus
Ryunha Kim +23 more
doaj +1 more source
Adverse Drug Reactions to a Daily Fixed-dose Combination Based Antituberculosis Treatment Regime in India’s National Tuberculosis Elimination Programme: A Prospective Cohort Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: In India, the daily weight-based, Fixed Dose Combination (FDC) Antituberculosis Treatment (ATT) regime under the National Tuberculosis Elimination Programme (NTEP) was introduced, replacing the previous intermittent regime with the ...
Kapil Mate +2 more
doaj +1 more source
Pharmaceuticals, 2023 Self-emulsifying drug delivery systems (SEDDSs) are lipid-based systems that are superior to other lipid-based oral drug delivery systems in terms of providing drug protection against the gastrointestinal (GI) environment, inhibition of drug efflux as ...
Daniélle van Staden +2 more
doaj +1 more source
Pyrazinamide Induced Polyarthralgia and Myalgia in a Case of Pulmonary Tuberculosis – A Case Report [PDF]
Journal of Krishna Institute of Medical Sciences University, 2021 Pyrazinamide Induced polyarthralgia is common but myalgia is an uncommon adverse drug reaction. Understanding a case with estimated peak plasma concentration correlation is very rarely performed.
Bijoy Kumar Panda +4 more
doaj
Frontiers in Cell and Developmental Biology, 2022 Rifampicin (RIF), Isoniazid (INH), Ethambutol (EMB), Pyrazinamide (PZA), and/or their fixed-dose combination (FDC) are extensively prescribed in the cure of Tuberculosis (TB) globally.
Adekunle A. Bakare +11 more
doaj +1 more source